| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Burrows Scott L is a Chief Financial Officer at SYRE with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $12.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2023 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,850 | $15.90 | $29,421.25 | -1.6% | -52.5% | -25.6% | |
| Mar 7, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sell | 303 | $16.85 | $5,104.17 | -0.4% | +24.5% | -17.1% | |
| Mar 1, 2022 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sell | 420 | $17.75 | $7,456.13 | -1.9% | +19.3% | -4.6% | |
| Dec 27, 2021 | ARQT Arcutis Biotherapeutics, Inc. | Chief Financial Officer | Sell | 12,560 | $20.07 | $252,139.49 | -35.6% | -13.7% | -30.5% |